Using exactly the same thinking, GlaxoSmithKline???s Ian Hudson argued that even though in scores of cases company employees had categorized a suicide or other problem as caused by their drug, because there was no statistically significant RCT data showing an increased relative risk on the drug these judgments were meaningless (Psychotic doubt).